Cytarabine

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19874 publications

Recurrent cystoid macular oedema associated with high-dose cytarabine therapy.

Recurrent cystoid macular oedema associated with high-dose cytarabine therapy.

Journal: Clinical & experimental optometry

Published: January 16, 2026

Structural and Functional Analysis of GGPPS Inhibition as a Therapeutic Mechanism for Acute Myeloid Leukemia (AML).

Structural and Functional Analysis of GGPPS Inhibition as a Therapeutic Mechanism for Acute Myeloid Leukemia (AML).

Journal: Research square

Published: January 09, 2026

Clinical Efficacy Analysis of 38 Pediatric Cases of Recurrent and Refractory Langerhans Cell Histiocytosis

Clinical Efficacy Analysis of 38 Pediatric Cases of Recurrent and Refractory Langerhans Cell Histiocytosis

Journal: Zhongguo shi yan xue ye xue za zhi

Published: January 08, 2026

Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphoma.

Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphoma.

Journal: Leukemia & lymphoma

Published: December 22, 2025

Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL).

Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL).

Journal: Neuro-oncology

Published: December 18, 2025

Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemia.

Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: December 18, 2025

Treatment with interferon α-1b, interleukin-2, and thalidomide for persistent RUNX1::RUNX1T1 in a patient with KIT-mutated acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review

Treatment with interferon α-1b, interleukin-2, and thalidomide for persistent RUNX1::RUNX1T1 in a patient with KIT-mutated acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 17, 2025

Relapsing Blastic Plasmacytoid Dendritic Cell Neoplasm With Neurologic Involvement.

Relapsing Blastic Plasmacytoid Dendritic Cell Neoplasm With Neurologic Involvement.

Journal: Cureus

Published: December 17, 2025

Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm study

Clinical efficacy and safety of CLAE regimen for refractory/relapsed T cell acute lymphoblastic leukemia/lymphoma: a prospective, multicenter, single-arm study

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 17, 2025

Targeting IMPDH to inhibit SAMHD1 in KMT2A-rearranged leukaemia.

Targeting IMPDH to inhibit SAMHD1 in KMT2A-rearranged leukaemia.

Journal: Cell cycle (Georgetown, Tex.)

Published: December 16, 2025

NAMPT inhibition uncovers therapeutic vulnerabilities to venetoclax and chemotherapy in acute myelogenous leukemia.

NAMPT inhibition uncovers therapeutic vulnerabilities to venetoclax and chemotherapy in acute myelogenous leukemia.

Journal: Leukemia & lymphoma

Published: December 16, 2025

It Is Not Always Metastasis: A Case Report of a Primary Nervous System Anaplastic Large Cell Lymphoma and the Relevance of Brain Biopsy.

It Is Not Always Metastasis: A Case Report of a Primary Nervous System Anaplastic Large Cell Lymphoma and the Relevance of Brain Biopsy.

Journal: Cureus

Published: December 11, 2025

Showing 1-12 of 19,874

Last Updated: 02/24/2026